Psoriasis and Mortality in the US: Data from the National Health and Nutrition Examination Survey.
Psoriasis is a multifactorial disease that has been associated with multiple systemic disorders. Despite its role in mediating cardiovascular, metabolic, and pulmonary disorders, few studies examined the independent mortality risk associated with psoriasis. To determine the independent relationship between psoriasis and all-cause mortality in a nationally-representative sample of the US population. Retrospective population-based cohort study of adults and adolescents > 10 years (n=13,031) who participated in National Health and Nutrition Examination Surveys (2003-2006; 2009-2010). Psoriasis status determined from self-reported medical history questionnaire. Mortality data linked from national databases. Psoriasis was present in 2.7% of the study population. Over an average 52.3 months median follow-up, psoriasis was significantly associated with increased mortality risk (HR 1.99, 95% CI 1.01 to 3.93; p=0.047), adjusting for demographics, smoking, and comorbidities, including cardiovascular disease, diabetes, chronic obstructive pulmonary disease, cancer, chronic kidney disease, and stroke. These comorbidities mediated 15.5%, 5.9%, 8.7%, 11.7%, 4.2%, and 4.7% of the association between psoriasis and mortality, respectively. Psoriasis is independently associated with an increased risk of mortality. This relationship is partially mediated by an increased prevalence of cardiovascular, infectious, and neoplastic disorders seen among psoriatics.